Therapeutic Apheresis Therapy for ABO-incompatible Renal Transplantations

Therapeutic Apheresis

Volumn 7, Issue 6, 2003, Pages 520-528

  Ishida, Hideki ^a   Tanabe, Kazunari ^a   Toma, Hiroshi ^a   Akiba, Takashi ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

ABO incompatible renal transplantation; Anti A or anti B antibodies; Apheresis; Novel immunosuppressive drugs; Splenectomy

Indexed keywords

15 DEOXYSPERGUALIN; BLOOD GROUP A ANTIBODY; BLOOD GROUP A ANTIGEN; BLOOD GROUP B ANTIBODY; BLOOD GROUP O ANTIGEN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS;

ALLOGRAFT; ALLOTRANSPLANTATION; APHERESIS; BLOOD GROUP A; BLOOD GROUP ABO INCOMPATIBILITY; BLOOD GROUP O; GRAFT SURVIVAL; HEPATITIS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; LIVING DONOR; PRIORITY JOURNAL; REVIEW; SPLENECTOMY;

ABO BLOOD-GROUP SYSTEM; BLOOD COMPONENT REMOVAL; BLOOD GROUP INCOMPATIBILITY; BLOOD-BRAIN BARRIER; COMBINED MODALITY THERAPY; FEMALE; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; ISOANTIBODIES; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; PROGNOSIS; RISK ASSESSMENT; SPLENECTOMY; SURVIVAL RATE; TRANSPLANTATION IMMUNOLOGY; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 0345732703     PISSN: 10916660     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1526-0968.2003.00099.x     Document Type: Review

References (26)

1. Landsteiner K. Cell antigens and individual specificity. J Immunol 1928;15:589-600.
2. Springer GE, Horton RE, Forbes M. Origin of anti-human blood group B agglutinins in white leghorn chicks. J Exp Med 1959;110:221-44.
3. Palmer A, Welsh K, Gjorstrup P. Removal of anti-HLA antibodies by extracorporeal immunoadsorption to enable renal transplantation. Lancet 1989;1:10-12.
4. Magee JC, Collins BH, Harland RC, Bollinger RR, Frank MM, Platt JL. Prevention of hyperacute xenograft rejection by intravenous immunoglobulin. J Clin Invest 1995;96:2404-12.
5. Michael AF, Falk RJ, Platt JL. Antigens of the human glomerulus. Adv Nephrol 1983;13:203-18.
6. Porter KA. Morphological aspects of renal homograft rejection. Br Med Bull 1965;21:171-5.
7. Wilbrandt R, Tung KSK, Deodhar SD. ABO blood group incompatibility in human renal homotransplantations. Am J Clin Pathol 1969;51:15-23.
8. Szuman AE. The histological distribution of blood group substances A and B in man. J Exp Med 1960;11:785-800.
9. Economidou J, Hugh Jones N, Gardner B. Quantitative measurements concerning AB antigens. Vox Sang 1967;12:321-8.
10. Ceppellini R, Bialiani S, Curtoni ES, Leigheb G. Experimental allotransplantation in man: The role of A1, A2 and B antigens. Transplant Proc 1969;1:390-4.
11. Rydberg L, Samuelsson BE, Brynger H. Blood group ABO-incompatible kidney transplantation in human subjects. Transplant Proc 1987;19:4528-37.
12. Welsh KI, Koffman CG, Bewick ME, Rudge CJ, Taube DH, Clark AGB. Transplantation of blood group A2 kidneys into O or B recipients. Transplant Proc 1987;19:4565-7.
13. Nelson PW, Landreneau MD, Luger AM et al. Ten years experience in transplantation of A2 kidneys into B and O recipients. Transplantation 1998;65:256-60.
14. Alkhunaizi AM, Barry JM, Bennet WM, Norman DJ. Renal transplantation across the ABO blood barrier using A2 kidneys. Transplantation 1999;67:1319-24.
15. Slapak M, Naik RB, Lee HA. Renal transplant in a patient with major donor-recipient blood group incompatibility. Transplantation 1981;31:4-7.
16. Alexandre GPJ. Squifflet JP, De Bruyere M, Latinne D, Pirson Y. Present experiences in a series of 26 ABO-incompatible living donor renal aloografts. Transplant Proc 1987;19:4538-42.
17. Takahashi K, Tanabe K, Ooba S et al. Prophylactic use of a new immunosuppressive agent, deoxyspergualine, in patients with kidney transplantation with ABO-incompatible or performed antibody positive donors. Transplant Proc 1991;23:1078-82.
18. Takahashi K, Saito K, Sonda K, Takeda M. Tacrolimus therapy for ABO-incompatible kidney transplantation. Transplant Proc 1998;30:1078-82.
19. Ishida H, Koyama I, Sawada T et al. Anti-AB titer changes in patients with ABO incompatibility after living related kidney transplantations. Transplantation 2000;70:681-5.
20. Shimmura H, Tanabe K, Ishikawa N, Takahashi K, Toma H. Role of ani-AB antibody titers in results of ABO-incompatible kidney transplantation. Transplantation 2000;70:1331-5.
21. Merkel FK, Bier M, Beavers CD. Modification of xenograft response by selective plasmapheresis. Transplant Proc 1971;3:534-7.
22. Shons AR, Bier M, Jetzer T. Techniques of in vivo plasma modification for the treatment of hyperactive rejection. Surgery 1973;73:28-37.
23. Ross CN, Gaskin G, Gregor-MacGregor S. Renal transplantation following immunoadsorption in highly sensitized recipients. Transplantation 1993;55:785-9.
24. Bannett AD, McAlack RF, Raja R et al. Experiences with known ABO-mismatched renal transplants. Transplant Proc 1987;19:4543-6.
25. Tanabe K, Takahashi K, Sonda K, Toma H, Agishi T, Ota K. Long term results of ABO-incompatible living kidney transplantation: A single-center experience. Transplantation 1998;65:224-30.
26. Galili U, Ishida H, Tanabe K, Toma H. Anti-Gal A/B, a novel anti-blood group antibody identified in recipients of ABO-incompatible kidney allografts. Transplantation 2002;74:1574-80.